Azenta, Inc. (NASDAQ:AZTA) Shares Sold by Charles Schwab Investment Management Inc.

Charles Schwab Investment Management Inc. lowered its stake in Azenta, Inc. (NASDAQ:AZTA - Free Report) by 4.3% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 413,539 shares of the company's stock after selling 18,696 shares during the quarter. Charles Schwab Investment Management Inc. owned 0.85% of Azenta worth $20,032,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. Kayne Anderson Rudnick Investment Management LLC increased its holdings in Azenta by 1.9% during the second quarter. Kayne Anderson Rudnick Investment Management LLC now owns 5,298,040 shares of the company's stock valued at $278,783,000 after buying an additional 100,826 shares during the last quarter. Dimensional Fund Advisors LP lifted its holdings in shares of Azenta by 16.5% in the 2nd quarter. Dimensional Fund Advisors LP now owns 2,970,964 shares of the company's stock valued at $156,331,000 after acquiring an additional 421,719 shares during the last quarter. Allspring Global Investments Holdings LLC raised its holdings in Azenta by 16.4% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 1,298,856 shares of the company's stock valued at $62,917,000 after buying an additional 183,040 shares during the period. Royce & Associates LP boosted its stake in shares of Azenta by 7.8% during the 3rd quarter. Royce & Associates LP now owns 739,977 shares of the company's stock worth $35,844,000 after purchasing an additional 53,584 shares during the period. Finally, Bank of New York Mellon Corp grew its stake in shares of Azenta by 3.8% during the second quarter. Bank of New York Mellon Corp now owns 515,393 shares of the company's stock valued at $27,120,000 after buying an additional 18,680 shares during the last quarter. Hedge funds and other institutional investors own 99.08% of the company's stock.

Insider Buying and Selling

In related news, Director William L. Cornog purchased 12,500 shares of the business's stock in a transaction dated Monday, November 18th. The stock was bought at an average cost of $39.60 per share, with a total value of $495,000.00. Following the completion of the acquisition, the director now directly owns 14,755 shares in the company, valued at $584,298. The trade was a 554.32 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Herman Cueto sold 1,595 shares of the stock in a transaction on Thursday, October 17th. The shares were sold at an average price of $43.68, for a total value of $69,669.60. Following the sale, the chief financial officer now directly owns 24,604 shares in the company, valued at approximately $1,074,702.72. The trade was a 6.09 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 3,018 shares of company stock valued at $126,689 over the last three months. 1.77% of the stock is currently owned by company insiders.

Analyst Ratings Changes

Several equities analysts have issued reports on AZTA shares. Evercore ISI cut their target price on Azenta from $53.00 to $50.00 and set an "in-line" rating on the stock in a research note on Tuesday, October 1st. Needham & Company LLC dropped their price objective on shares of Azenta from $69.00 to $55.00 and set a "buy" rating on the stock in a report on Wednesday, November 13th. Three investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the company presently has an average rating of "Hold" and a consensus target price of $63.60.

Azenta Trading Up 1.3 %

NASDAQ:AZTA traded up $0.59 during midday trading on Friday, reaching $45.59. The company had a trading volume of 352,481 shares, compared to its average volume of 1,246,025. The stock's fifty day simple moving average is $44.72 and its 200-day simple moving average is $49.70. Azenta, Inc. has a 12-month low of $38.82 and a 12-month high of $69.16. The firm has a market capitalization of $2.08 billion, a price-to-earnings ratio of -15.35 and a beta of 1.49.

Azenta (NASDAQ:AZTA - Get Free Report) last released its quarterly earnings data on Tuesday, November 12th. The company reported $0.18 earnings per share for the quarter, topping analysts' consensus estimates of $0.10 by $0.08. The company had revenue of $170.00 million for the quarter, compared to analysts' expectations of $169.66 million. Azenta had a negative net margin of 25.01% and a positive return on equity of 1.03%. The firm's revenue for the quarter was down 1.2% on a year-over-year basis. During the same quarter last year, the company earned $0.13 earnings per share. As a group, sell-side analysts expect that Azenta, Inc. will post 0.41 EPS for the current year.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.